My bookmarksSign up free
Source

Commission Implementing Regulation (EU) 2023/943 of 11 May 2023 authorising the placing on the market of cellobiose as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

Commission Implementing Regulation (EU) 2023/943 of 11 May 2023 authorising the placing on the market of cellobiose as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

Implementing Regulation (EU) 2023/943 · Regulation · 5 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

1.   Cellobiose is authorised to be placed on the market within the Union. Cellobiose shall be included in the Union list of novel foods set out in Implementing Regulation (EU) 2017/2470. 2.   The Annex to Implementing Regulation (EU) 2017/2470 is amended in accordance with the Annex to this Regulation.

Article 2

Open ↗

Only the company SAVANNA Ingredients GmbH  ( 11 ) is authorised to place on the market within the Union the novel food referred to in Article 1, for a period of five years from 1 June 2023, unless a subsequent applicant obtains an authorisation for that novel food without reference to the scientific data protected pursuant to Article 3 or with the agreement of SAVANNA Ingredients GmbH.

Article 3

Open ↗

The scientific data contained in the application file and fulfilling the conditions laid down in Article 26(2) of Regulation (EU) 2015/2283 shall not be used for the benefit of a subsequent applicant for a period of five years from the date of entry into force of this Regulation without the agreement of SAVANNA Ingredients GmbH.

Article 4

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX The Annex to Implementing Regulation (EU) 2017/2470 is amended as follows: (1) in Table 1 (Authorised novel foods), the following entry is inserted: Authorised novel food Conditions under which the novel food may be used Additional specific labelling requirements Other requirements Data protection ‘ Cellobiose Specified food category Maximum levels 1. The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘cellobiose’. 2. The labelling of food supplements containing cellobiose shall bear a statement that those food supplements should not be consumed by infants and young children.   Authorised on 1 June 2023. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: SAVANNA Ingredients GmbH, Dürener Straße 67, 50189 Elsdorf, Germany. During the period of data protection, the novel food cellobiose is authorised for placing on the market within the Union only by SAVANNA Ingredients GmbH, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of SAVANNA Ingredients GmbH. End date of the data protection: 1 June 2028.’ Food supplements as defined in Directive 2002/46/EC for the general population, excluding infants and young children 3 g/day Dried, canned-tinned, raw cured (or seasoned), cooked cured (or seasoned) meat 2 g/100 g Fresh raw, preserved or partly preserved sausages 2 g/100 g Meat based spreadable-textured specialties 2 g/100 g Liver based spreadable-textured specialties 2 g/100 g Savoury sauce dry preparation 40 g/100 g Table-top sweeteners in powder form 60 g/100 g Table-top sweeteners in tablets 60 g/100 g (2) in Table 2 (Specifications), the following entry is inserted: Authorised Novel Food Specification ‘ Cellobiose Description/Definition: Cellobiose is a disaccharide with two glucose monomers linked by a β-(1–4) glucosidic bond, that is produced from sucrose and glucose in a two-step enzymatic reaction, followed by a series of purification steps. Characteristics/composition: Cellobiose DM (%): ≥ 99 Moisture (%): < 1 Other identified sugars (%): ≤ 1 Optical rotation [α] D (c 10, water): +33–36 Ash (g/100 g): < 0,1 Protein content (g/100 g): < 0,01 Heavy metals: Arsenic: < 0,1 mg/kg Microbiological criteria: Total aerobic count (cfu/g): ≤ 1 000 Yeast and moulds (cfu/g): ≤ 100 Salmonella (in 25 g): n.d. Coliforms (cfu/g): ≤ 10 E. coli (in 10 g): n.d. cfu: colony forming units n.d.: not detected’

Other acts of the same type
Commission Implementing Regulation (EU) 2017/408 of 8 March 2017 approving the low-risk active substance Mild Pepino Mosaic Virus isolate VC1, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance. )Commission Implementing Regulation (EU) 2017/409 of 8 March 2017 approving the basic substance hydrogen peroxide in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance. )Commission Implementing Regulation (EU) 2017/410 of 8 March 2017 amending Regulations (EC) No 184/2007 and (EU) No 104/2010, as regards the name of the holder of the authorisation of potassium diformate (Text with EEA relevance. )Commission Delegated Regulation (EU) 2017/653 of 8 March 2017 supplementing Regulation (EU) No 1286/2014 of the European Parliament and of the Council on key information documents for packaged retail and insurance-based investment products (PRIIPs) by laying down regulatory technical standards with regard to the presentation, content, review and revision of key information documents and the conditions for fulfilling the requirement to provide such documents (Text with EEA relevance. )Council Implementing Regulation (EU) 2017/395 of 7 March 2017 implementing Article 13 of Regulation (EU) No 356/2010 imposing certain specific restrictive measures directed against certain natural or legal persons, entities or bodies, in view of the situation in SomaliaCouncil Implementing Regulation (EU) 2017/396 of 7 March 2017 implementing Article 9(5) of Regulation (EC) No 1183/2005 imposing certain specific restrictive measures directed against persons acting in violation of the arms embargo with regard to the Democratic Republic of the CongoCouncil Regulation (EU) 2017/400 of 7 March 2017 amending Regulation (EU) No 224/2014 concerning restrictive measures in view of the situation in the Central African RepublicCouncil Implementing Regulation (EU) 2017/401 of 7 March 2017 implementing Article 15(3) of Regulation (EU) No 747/2014 concerning restrictive measures in view of the situation in SudanCouncil Implementing Regulation (EU) 2017/402 of 7 March 2017 implementing Article 20(3) of Regulation (EU) 2015/735 concerning restrictive measures in respect of the situation in South SudanCouncil Implementing Regulation (EU) 2017/403 of 7 March 2017 implementing Article 11(1) of Regulation (EU) No 377/2012 concerning restrictive measures directed against certain persons, entities and bodies threatening the peace, security or stability of the Republic of Guinea-BissauCouncil Implementing Regulation (EU) 2017/404 of 7 March 2017 implementing Article 11(4) of Regulation (EU) No 753/2011 concerning restrictive measures directed against certain individuals, groups, undertakings and entities in view of the situation in AfghanistanCouncil Implementing Regulation (EU) 2017/374 of 3 March 2017 implementing Regulation (EU) No 208/2014 concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in Ukraine

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next